Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Erythropoietin in myocardial infarction

Trial Profile

Erythropoietin in myocardial infarction

Phase of Trial: Phase II

Latest Information Update: 04 Jul 2012

At a glance

  • Drugs Epoetin beta (Primary)
  • Indications Left ventricular dysfunction; Myocardial infarction
  • Focus Pharmacodynamics
  • Acronyms EPOMI
  • Most Recent Events

    • 01 Feb 2012 Primary endpoint 'Myocardial-infarct-size' has not been met.
    • 01 Feb 2012 Results published in the American Heart Journal.
    • 28 Jan 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top